Clinical Trials Directory

Trials / Completed

CompletedNCT06223620

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

Status
Completed
Phase
Study type
Observational
Enrollment
504 (actual)
Sponsor
Methodist Health System · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.

Detailed description

Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Plan to perform a retrospective review of management protocols at these institutions. Wish to know whether the implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity. The objective of the study is to review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity. Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Hypothesize that implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

Conditions

Interventions

TypeNameDescription
OTHERreview performance of water soluble contrastreview performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

Timeline

Start date
2018-07-30
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2024-01-25
Last updated
2026-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06223620. Inclusion in this directory is not an endorsement.